Department of Biochemistry and Structural Biology, The University of Texas Health Science Center, San Antonio, TX, United States.
Med Hypotheses. 2018 Jan;110:60-63. doi: 10.1016/j.mehy.2017.11.001. Epub 2017 Nov 6.
The cause and therapy of neurodegenerative diseases remain unsolved puzzles. These diseases are correlated with presence of beta sheet-rich amyloid assemblies. Here, I derive and assemble puzzle pieces to obtain a loose end-tying hypothesis for cause with direct implications for therapy. I use the following extrapolations to find connectable puzzle pieces: (a) the traditional extrapolation that amyloid/amyloid precursors cause disease, (b) a recent extrapolation that amyloid-forming proteins, some of which are virus protein homologs, are components of an empirically obscure innate immune system that counters insults, including those by both viruses and bacteria, (c) a new extrapolation that various insults produce assemblies with structural features in common and that amyloid-forming, innate immune system proteins recognize these features and, then, counter insults by co-assembly, (d, 1) a second new extrapolation that beta sheet is a common structural feature and is extended during insult-neutralizing co-assembly and (d, 2) an appendix, derived from studies of phages T3 and T4, that most insult-produced assemblies are obscure to current biochemical analysis. The hypothesis is the following. One function of amyloid-forming proteins is non-classical innate immunity to biological insults. This immunity works via beta sheet-extending co-assembly of amyloid-forming proteins with beta sheet-containing insult products. For example, co-assembly with beta sheet-containing viral assembly intermediates inhibits virus production. Amyloid-forming proteins cause neurodegenerative disease when errant, typically overproduced. Other innate immunity systems sometimes exacerbate symptoms. This hypothesis suggests the following therapy, based on manipulating Nature's chemistry. First, conduct directed evolution to obtain low-pathogenicity, chronic symptom-producing viruses with assembly intermediates that co-assemble with and destabilize both amyloid and amyloid sub-assemblies. Then, infect patients with these viruses.
神经退行性疾病的病因和治疗仍然是未解之谜。这些疾病与富含β片层的淀粉样组装体的存在有关。在这里,我推导出并组装拼图块,以获得一个松散的因果关系假说,该假说对治疗有直接影响。我使用以下外推来寻找可连接的拼图块:(a)淀粉样蛋白/淀粉样前体导致疾病的传统外推,(b)最近的外推,即淀粉样形成蛋白,其中一些是病毒蛋白同源物,是一种经验上模糊的先天免疫系统的组成部分,该系统可以对抗包括病毒和细菌在内的各种攻击,(c)一种新的外推,即各种攻击会产生具有共同结构特征的组装体,并且淀粉样形成的先天免疫系统蛋白识别这些特征,然后通过共组装来对抗攻击,(d,1)另一个新的外推,即β片层是一种常见的结构特征,并且在中和攻击的共组装过程中得到扩展,(d,2)一个附录,源自噬菌体 T3 和 T4 的研究,表明大多数由攻击产生的组装体对当前的生化分析来说是模糊的。假设如下。淀粉样形成蛋白的一个功能是对生物攻击的非经典先天免疫。这种免疫作用是通过淀粉样形成蛋白与含有β片层的攻击产物的β片层扩展共组装来实现的。例如,与含有β片层的病毒组装中间体的共组装会抑制病毒的产生。淀粉样形成蛋白在错误的情况下,通常是过度产生时,会导致神经退行性疾病。其他先天免疫系统有时会加重症状。该假说提出了以下基于操纵自然化学的治疗方法。首先,进行定向进化,获得具有与淀粉样和淀粉样亚组装体共组装并使其不稳定的组装中间体的低致病性、慢性症状产生的病毒。然后,用这些病毒感染患者。